James Langevin on Stem Cell Research

Last Updated : May 06, 2010

Voting Record

Stem Cell Research Enhancement Act of 2007

The bill came back up for another vote in roll call 443 where it passed 247-146 before it was vetoed by President Bush. James Langevin voted in favor of the Stem Cell Research Enhancement Act of 2007.

James Langevin voted in favor of the Stem Cell Research Enhancement Act of 2007.

Stem Cell Research Enhancement Act of 2007

In January 2007, the Senate passed S 5 - the Stem Cell Research Enhancement Act with wide support from Democrats and moderate support from Republicans. The Act required the Secretary of Health and Human Services to conduct and support research that utilizes human embryonic stem cells, regardless of the date on which the stem cells were derived from a human embryo. Specific limitations were put in place to ensure that the embryos would not have been used for other purposes and were not created specifically for research. The bill passed both the house and senate, but was vetoed by President Bush. James Langevin voted in favor of theStem Cell Research Enhancement Act of 2007.

James Langevin voted in favor of theStem Cell Research Enhancement Act of 2007.

Stem Cell Research Enhancement Act of 2005

In 2006, an initial effort to pass a stem cell research bill through congress was also vetoed by President Bush. The veto override failed to achieve the necessary 2/3 majority.. James Langevin voted in favor of overturning the veto on the Stem Cell Research Enhancement Act of 2005.

James Langevin voted in favor of overturning the veto on the Stem Cell Research Enhancement Act of 2005.

The Alternative Pluripotent Stem Cell Therapies Enhancement Act

In 2006, the Senate passed the Alternative Pluripotent Stem Cell Therapies Enhancement Act. Although it was widely supported in the Senate, it did not reach the 2/3 necessary to pass the House without objection in a 273-154 vote. James Langevin voted in favor of the Alternative Pluripotent Stem Cell Therapies Enhancement Act.

James Langevin voted in favor of the Alternative Pluripotent Stem Cell Therapies Enhancement Act.

Stem Cell Therapeutic and Research Act of 2005

In 2005, Congress passed the Stem Cell Therapeutic and Research Act of 2005. The bill set up requirements for the Secretary of Health and Human Services to contract with qualified cord blood stem cell banks to assist in the '); echo('collection and maintenance of 150,000 new units of high-quality cord blood to be made available for transplantation through the C.W. Bill Young Cell Transplantation Program. The bill passed almost unanimously in roll call 205. James Langevin voted in favor of the Stem Cell Therapeutic and Research Act of 2005.

James Langevin voted in favor of the Stem Cell Therapeutic and Research Act of 2005.

Stem Cell Research Enhancement Act

In May of 2005, the House passed the Stem Cell Research Enhancement Act. This legislation would have allowed research on human embryonic stem cells created after President Bush's 2001 deadline. The measure passed the House and Senate, but was vetoed. It passed the House 238-194. James Langevin voted in favor of the Stem Cell Research Enhancement Act.

James Langevin voted in favor of the Stem Cell Research Enhancement Act.

 

Sponsored and Cosponsored Legislation

Session-111; Bill Number-H R 4808; Stem Cell Research Advancement Act of 2009 - Cosponsor

Amends the Public Health Service Act to require the Secretary of Health and Human Services (HHS) to conduct and support research that utilizes human stem cells, including human embryonic stem cells. Limits such research to stem cells that meet the following requirements: (1) the stem cells were derived from human embryos donated from in vitro fertilization clinics, were created for the purposes of reproductive treatment, and were in excess of the needs of the individuals seeking such treatment; (2) it was determined through consultation with the individuals seeking reproductive treatment that the embryos would never be implanted in a woman and would otherwise be discarded; and (3) the individuals seeking reproductive treatment donated the embryos with written informed consent and received no financial or other inducements.

Session-111; Bill Number-H R 873; Stem Cell Research Enhancement Act of 2009 - Cosponsor

Amends the Public Health Service Act to require the Secretary of Health and Human Services to conduct and support research that utilizes human embryonic stem cells, regardless of the date on which the stem cells were derived from a human embryo. Limits such research to stem cells that meet the following requirements: (1) the stem cells were derived from human embryos donated from in vitro fertilization clinics, were created for the purposes of fertility treatment, and were in excess of the needs of the individuals seeking such treatment; (2) prior to donation, it was determined that the embryos would never be implanted in a woman and would otherwise be discarded; and (3) the individuals seeking fertility treatment donated the embryos with written informed consent and received no financial or other inducements.

Session-110; Bill Number-H R 3; Stem Cell Research Enhancement Act of 2007 - Cosponsor

To amend the Public Health Service Act to provide for human embryonic stem cell research.

User Comments